HAE Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about HAE clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 187 trials

Recruiting
Phase 3

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Autoimmune Haemolytic Anaemia
Sanofi90 enrolled91 locationsNCT07086976
Recruiting
Phase 3

EVE TRIAL , ALMA SYSTAM

Postpartum Haemorrhage (PPH)PPHPostpartum Hemorrhage (Primary)
ResQ Medical Ltd50 enrolled2 locationsNCT06646653
Recruiting
Not Applicable

Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care

Cerebral PalsyPremature BirthNeurological Disorder+1 more
University of Wisconsin, Madison225 enrolled1 locationNCT06643598
Recruiting
Phase 1

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

Haemophilia A
Novo Nordisk A/S30 enrolled22 locationsNCT07220564
Recruiting
Phase 3

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Myasthaenia Gravis
Cartesian Therapeutics100 enrolled34 locationsNCT06799247
Recruiting
Phase 4

A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India

Severe Postpartum Haemorrhage
Novo Nordisk A/S64 enrolled8 locationsNCT07157423
Recruiting
Phase 2Phase 3

Minocycline in Stroke Study at Maimonides

Cerebrovascular Accident (Stroke)StrokeMortality+4 more
Joyce Chen1,164 enrolled1 locationNCT07237048
Recruiting
Not Applicable

Investigating the Tolerability and Feasibility of tVNS Following aSAH

Subarachnoid Haemorrhage From Cerebral Aneurism Rupture
Sheffield Teaching Hospitals NHS Foundation Trust30 enrolled1 locationNCT06374693
Recruiting

ALI & Pulmonary HA Deposition After SAH

Subarachnoid Haemorrhage (SAH)
Tianjin Medical University24 enrolled1 locationNCT06628531
Recruiting
Phase 3

Donidalorsen Treatment in Children With Hereditary Angioedema

Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc.20 enrolled3 locationsNCT07298447
Recruiting
Phase 3

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V.170 enrolled24 locationsNCT06679881
Recruiting
Not Applicable

Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease

HaemorrhoidsInternal HaemorrhoidsGrade II/III Haemorrhoids
Centre Hospitalier Departemental Vendee168 enrolled18 locationsNCT06170736
Recruiting

Genetics of Neonatal Encephalopathy and Related Disorders

Neonatal EncephalopathyHypoxic Ischaemic Encephalopathy (HIE)
Boston Children's Hospital300 enrolled1 locationNCT07165938
Recruiting

The CACHE Study: Coronary Artery Care in HaEmophilia

HaemophiliaCardiovascular Diseases
Oxford University Hospitals NHS Trust80 enrolled1 locationNCT06706206
Recruiting
Phase 1

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

Haematologic Neoplasms
AstraZeneca72 enrolled21 locationsNCT07064122
Recruiting
Phase 3

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary AngioedemaHereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled14 locationsNCT06960213
Recruiting

A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

Hereditary Angioedema (HAE)
Takeda40 enrolled24 locationsNCT07251933
Recruiting
Phase 3

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

Haemophilia A
Sinocelltech Ltd.36 enrolled1 locationNCT07437404
Recruiting

Internal Jugular Vein Ultrasound for Volume Status Assessment in Haemodialysis

Point of Care Ultrasound (POCUS)HaemodialysisVolume Assessment
University of Bologna100 enrolled1 locationNCT07438613
Recruiting

International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)

Dengue FeverDengue DiseaseDengue Haemorrhagic Fever+1 more
Mahidol University100 enrolled1 locationNCT07409857